Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3336 results

Sort By:

Intermittent Fasting on the Blood Microbiome

Study ID: NCT06678516
Start Date: 2025-12-01
End Date: 2026-01-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

48

Intervention / Treatment

Intermittent fasting

Sponsor

Erasmus Medical Center

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP

Study ID: NCT07024316
Start Date: 2025-11-01
End Date: 2027-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

6

Intervention / Treatment

ATL-001 (Ciclopirox oral solution)

Sponsor

Atlas Molecular Pharma

Source: clinicaltrials.gov

Share:
Add to list

Study of NM8074 in Adult C3 Glomerulopathy Patients

Study ID: NCT05647811
Start Date: 2025-11
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

18

Intervention / Treatment

Nm8074

Sponsor

NovelMed Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Oral Health-Related Quality of Life In Patients With Conventional Complete Dentures Versus Mini-Implant Retained Overdentures: A Randomized Clinical Trial

Study ID: NCT07080164
Start Date: 2025-11-01
End Date: 2027-11-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

mini implant retained overdenture

Sponsor

Cairo University

Source: clinicaltrials.gov

Share:
Add to list

Tirzepatide in MetALD

Study ID: NCT07046819
Start Date: 2025-09-10
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Tirzepatide

Placebo

Sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

Study ID: NCT07146906
Start Date: 2025-11-18
End Date: 2030-07-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

32

Intervention / Treatment

ZigaKiBart

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

The Longitudinal Impact of SES and the CNDS on Recovery From SUD

Study ID: NCT05103514
Start Date: 2025-12-01
End Date: 2028-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

675

Intervention / Treatment

Online Survey

Sponsor

Virginia Polytechnic Institute and State University

Source: clinicaltrials.gov

Share:
Add to list

Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON)

Study ID: NCT06283238
Start Date: 2025-10-17
End Date: 2027-03-25
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Immune checkpoint inhibitor (ICI) or chemotherapy alone

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Promoting Healthy Children and Youth

Study ID: NCT06977438
Start Date: 2026-01-01
End Date: 2031-01-31
Study Type

Interventional

Study Phase

Phase4

No. of Participants

1020

Intervention / Treatment

Semglutide

Sponsor

The University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

Wellness, Alcohol, Vitals, and Emotions

Study ID: NCT06982443
Start Date: 2025-10-01
End Date: 2029-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Mindfulness based relapse prevention

Sponsor

University of New Mexico

Source: clinicaltrials.gov

Share:
Add to list